Title: Malignant Leydig Cell Tumor of Testis: Case Report

Authors: Dr Himani Thakur, Dr Sarita Asotra, Dr Kavita Mardi, Dr Kailash Mohan Bhandari, Dr Kavita Kumari

 DOI: https://dx.doi.org/10.18535/jmscr/v12i05.01

Abstract

Testicular tumors accounts for % of the tumors in men. 5% of which are the sex cord stromal tumors and the remaining are of germ cell origin. Leydig cell are the common subtype of Sex cord stromal tumors and accounts for 1%-2% of all the testicular tumors. Tumor arises from the leydig cells that normally reside in the interstitium of testicles and secrete testosterone in the presence of leutenizing hormone. They show a bimodal distribution with peaks in the prepubertal age group and between 30-60yrs of age. Leydig cell tumor being a hormonally active tumor often presents with precocious puberty, breast tenderness and gynaecomastia. Histopathology reveals a well circumscribed mass .Cut surface shows golden brown homogenous appearance. Microscopically, tumor cells are large to polygonal with round to oval nucleus with deeply granular cytoplasm. Cytoplasm shows characteristics rod sghaped crystals referred to as “ crystalloids of Reinke”. Leydig cell tumors are mostly follow a benign course but approximately 5-10% of these have malignant potential. Regional lymph nodes, lungs , liver and bones are the commonest sites of metastsis. Due to aggressive difficult to treat nature of metastatic disease it is essential to differentiate benign leydig cell tumor from its malignant counterpart in order to guide its initial surgical and radiological management. Assessment of the clinicopathological features of Leydig cell tumor allows for its optimal management.

References

  1. Zhu J, Luan Y, Li H. Management of testicular Leydig cell tumor: a case report. Medicine. 2018 Jun;97(25).
  2. Pomajzl AJ, Siref LE. Leydig Cell Cancer.
  3. David J, Chumbalkar V, Chadha J. An insight into metastatic Leydig cell tumors: A case report. SAGE Open Medical Case Reports. 2023 Jul;11:2050313X231184180.
  4. Carroll HK, Nolis T, Darwish W, Harrison M, McCaffrey JA. Leydig cell tumours: a case series from a single Irish centre. SN Comprehensive Clinical Medicine. 2021 Jun;3:1307-12.
  5. Gheorghisan-Galateanu AA. Leydig cell tumors of the testis: a case report. BMC Research Notes. 2014 Dec;7:1-6.
  6. Al-Agha OM, Axiotis CA. An in-depth look at Leydig cell tumor of the testis. Archives of pathology & laboratory medicine. 2007 Feb 1;131(2):311-7.
  7. Leonhartsberger N, Ramoner R, Aigner F, Stoehr B, Pichler R, Zangerl F, Fritzer A, Steiner H. Increased incidence of Leydig cell tumours of the testis in the era of improved imaging techniques. BJU international. 2011 Nov;108(10):1603-7.
  8. Damjanov IV, Katz SM, Jewett MA. Leydig cell tumors of the testis. Annals of Clinical & Laboratory Science. 1979 Mar 1;9(2):157-63.
  9. Mati W, Lam G, Dahl C, Andersen JT, Balslev E. Leydig cell tumour–a rare testicular tumour. International urology and nephrology. 2002 Mar;33:103-5.
  10. Grem JL, Robins HI, Wilson KS, Gilchrist K, Trump DL. Metastatic leydig cell tumor of the testis report of three cases and review of the literature. Cancer. 1986 Nov 1;58(9):2116-9.

Corresponding Author

Dr Sarita Asotra

Professor Department of Pathology IGMC Shimla, India